Veillette, André
Lu, Yan
Article History
First Online: 17 September 2018
Competing interests
: A.V. has a contract with Bristol Myers-Squibb to study the mechanism of action of the monoclonal antibody elotuzumab (antibody to SLAMF7) in multiple myeloma.